Literature DB >> 27226519

Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials.

Sheng Zhang, Fei Liang, Wenfeng Li, Ian Tannock.   

Abstract

Trial registration and public accessibility of appended or published protocols of phase III randomized clinical trials (RCTs) allow comparison of reported research with essential aspects of trial design. We determined how eligibility criteria of participants specified in protocols were described in trial registries and articles of 255 cancer RCTs published in leading journals. The mean proportion of matching eligibility criteria between protocols and publications per trial (the primary endpoint) was 44.0% (95% confidence interval [CI] = 40.8% to 47.3%). Almost all discrepancies in eligibility criteria (96.7%, 95% CI = 96.1% to 97.3%) suggested to readers of articles that a broader study population was included. The mean proportion of matching eligibility criteria between protocols and registries was 72.9% (95% CI = 68.2% to 77.7%, the secondary endpoint). We conclude that there are substantial differences in eligibility criteria between trial protocols, registries and articles. Inaccurate reporting of eligibility criteria may prevent appropriate assessment of the applicability of trial results.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27226519     DOI: 10.1093/jnci/djw129

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

Review 1.  Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.

Authors:  D Shepshelovich; H Goldvaser; L Wang; A R Abdul Razak; P L Bedard
Journal:  Invest New Drugs       Date:  2017-09-14       Impact factor: 3.850

2.  Update on Trial Registration 11 Years after the ICMJE Policy Was Established.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Thiyagu Rajakannan
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

3.  Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.

Authors:  Fei Liang; Xinmei Guo; Sheng Zhang; Hongxi Xue; Qiang Chen; Xichun Hu
Journal:  Oncotarget       Date:  2017-10-03

4.  Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic review.

Authors:  Jinzhang He; Daniel R Morales; Bruce Guthrie
Journal:  Trials       Date:  2020-02-26       Impact factor: 2.279

5.  Publication Rate and Consistency of Registered Trials of Motor-Based Stroke Rehabilitation.

Authors:  Raabeae Aryan; David Jagroop; Cynthia J Danells; Gabriela Rozanski; Janelle Unger; Andrew H Huntley; Avril Mansfield
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

6.  Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis.

Authors:  Sierra Cheng; Mahin Qureshi; Eleanor Pullenayegum; Adam Haynes; Kelvin Kw Chan
Journal:  ESMO Open       Date:  2017-09-21

7.  Promoting public access to clinical trial protocols: challenges and recommendations.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson
Journal:  Trials       Date:  2018-02-17       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.